Headlines about Phibro Animal Health (NASDAQ:PAHC) have been trending somewhat positive this week, Accern reports. The research group scores the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Phibro Animal Health earned a coverage optimism score of 0.20 on Accern’s scale. Accern also gave news stories about the company an impact score of 45.9761654201775 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Several research firms recently issued reports on PAHC. BidaskClub lowered shares of Phibro Animal Health from a “sell” rating to a “strong sell” rating in a report on Friday, December 29th. Piper Jaffray Companies reissued a “buy” rating and issued a $42.00 target price on shares of Phibro Animal Health in a report on Friday, November 10th. ValuEngine lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a report on Thursday, November 9th. Finally, Zacks Investment Research lowered shares of Phibro Animal Health from a “hold” rating to a “sell” rating in a report on Wednesday, November 8th. Three equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of $38.25.

Shares of Phibro Animal Health (PAHC) opened at $35.30 on Friday. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. Phibro Animal Health has a fifty-two week low of $26.10 and a fifty-two week high of $40.25. The stock has a market cap of $1,420.00, a P/E ratio of 20.76, a P/E/G ratio of 4.03 and a beta of 1.27.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, November 6th. The company reported $0.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.37 by $0.01. Phibro Animal Health had a net margin of 8.87% and a return on equity of 42.75%. The business had revenue of $193.40 million during the quarter, compared to analyst estimates of $189.89 million. During the same period last year, the firm posted $0.36 EPS. The company’s revenue was up 2.9% on a year-over-year basis. analysts predict that Phibro Animal Health will post 1.57 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 27th. Shareholders of record on Wednesday, December 6th were issued a dividend of $0.10 per share. This represents a $0.40 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Tuesday, December 5th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 23.53%.

TRADEMARK VIOLATION NOTICE: This piece of content was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2018/01/06/phibro-animal-health-pahc-getting-somewhat-positive-media-coverage-report-finds.html.

About Phibro Animal Health

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Insider Buying and Selling by Quarter for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Stock Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related stocks with our FREE daily email newsletter.